AlphaClone Launches International ETF

AlphaClone, Inc. (“AlphaClone”), a pioneer in building accessible, alpha-seeking investment strategies for long-term investors, today launched the AlphaClone International ETF (NYSE: ALFI), which tracks the AlphaClone International Downside Hedged Index that was unveiled last week.

By accessing the investment ideas of the world’s most established hedge fund managers, the ETF seeks to give investors the potential to outperform broader international markets while simultaneously hedging against protracted market downturns. This is the firm’s second ETF on the market – the AlphaClone Alternative Alpha ETF (NYSE: ALFA), the first of its kind to track hedge fund holdings, launched in 2012 and has won significant market adoption.

“Following similar methodology inside separately managed accounts since 2010, we’re excited to offer an international ETF to help long-term investors navigate international opportunities,” said Maz Jadallah, CEO of AlphaClone. “Our approach seeks to combine the best of man and machine by leveraging the most established investors while offering a rules-based investment methodology.”

The index uses AlphaClone’s proprietary Clone Score methodology to continuously score managers based on the efficacy of following their disclosures, then aggregates at least 40 high conviction American Depository Receipt (ADR) holdings from managers with the highest score. Holdings are weighted based on the number of holders and are adjusted and weighted quarterly at pre-defined intervals. The International Downside Hedged Index also employs the firm’s innovative dynamic hedge mechanism that allows it to vary from long-only to market-hedged when the S&P 500 closes below its 200-day simple moving average at any month’s end.

“Pursuing the potential for alpha is even more important today for long-term investors given the anemic growth forecasted for equities and bonds over the next several years,” Jadallah continues. “Our strategies seek to offer long-term investors the ability to pursue alpha but with the benefits of a passive investment vehicle.”

For more information about AlphaClone, please visit To learn more about ALFI, please visit

About AlphaClone, Inc.

AlphaClone, Inc. is a San Francisco-based registered investment advisor and equity research firm that is a pioneer in building accessible alpha-seeking investment strategies for long-term investors. AlphaClone's investment products and solutions are derived from institutional investor public disclosures and give investors direct access to the investment ideas of the world’s most established hedge funds. The firm's proven, intelligent, risk-managed portfolio construction approach seeks to provide liquid, transparent, low-fee strategies that can give investors exposure to the alpha potential inherent in hedge fund investments. AlphaClone's investment research and strategies are available to investors through managed accounts and exchange-traded funds.

The fund’s investment objectives, risks, charges and expenses must be considered carefully before investing. The prospectus and summary prospectus contains this and other important information about the investment company, and it may be obtained by calling 1-800-617-0004 or visiting Read it carefully before investing.

Investments involve risk. Principal loss is possible. The AlphaClone Alternative Alpha ETF has the same risks as the underlying securities traded on the exchange throughout the day. Redemptions are limited and often commissions are charged on each trade, and ETFs may trade at a premium or discount to their net asset value. The AlphaClone Alternative ETF can make short sales of securities, which involves the risk that losses in securities may exceed the original amount invested in a security. The AlphaClone International ETF fund is non-diversified, meaning they may concentrate their assets in fewer individual holdings than a diversified fund. The AlphaClone International ETF fund invests in foreign securities which involve greater volatility and political, economic and currency risks and differences in accounting methods. These risks are greater in emerging markets. Therefore, the fund is more exposed to individual stock volatility than a diversified fund. REITs may be affected by changes in the value of their underlying properties or mortgages or by defaults by their borrowers or tenants. Furthermore, these entities depend upon specialized management skills, have limited diversification and are, therefore, subject to risks inherent in financing a limited number of projects. In addition, the performance of a REIT may be affected by changes in the tax laws or by its failure to qualify for tax-free pass-through of income. Investments in securities of MLPs involve risks that differ from an investment in common stock. Holders of the units of MLPs have more limited control and limited rights to vote on matters affecting the partnership. There are also certain tax risks associated with an investment in units of MLPs. In addition, conflicts of interest may exist between common unit holders, subordinated unit holders and the general partner of a MLP, including a conflict arising as a result of incentive distribution payments. The performance of the funds may diverge from that of their Index. Because the funds employ a representative sampling strategy and may also invest up to 20% of its assets in securities that are not included in the Index, or may overweight or underweight certain components of the Index, they may experience tracking error to a greater extent than a fund that seeks to replicate an index. The funds are not actively managed and may be affected by a general decline in market segments related to the index. The funds invest in securities included in, or representative of securities included in, their index, regardless of their investment merits. Outside the index construction rules, the funds do not take defensive positions under any market conditions, including conditions that are adverse to the performance of the funds. Changes in currency exchange rates and the relative value of non-U.S. currencies may affect the value of the ADRs and the value of your Fund shares. Investing in small cap companies involve additional risks such as limited liquidity and greater volatility than large companies.

The AlphaClone International Downside Hedged Index represents American Depository Receipts (ADR) securities that are favored by hedge funds and institutional investors in their public disclosures. The index is equal weighted with an overlap bias which gives a security held by twice the number of managers twice the weight. The index is reconstituted quarterly and can vary between being long only and market neutral. The index's adjustment in long/short positions does not guarantee against market loss. The S&P 500 Index is an unmanaged market index generally considered representative of the stock market as a whole. The index focuses on the Large-Cap segment of the U.S. Equities market. It is not possible to invest directly in an unmanaged index. This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. Alpha is the abnormal rate of return on a security or portfolio in excess of what would be predicted by an equilibrium model like the capital asset pricing model (CAPM).

The AlphaClone ETFs are distributed by Quasar Distributors, LLC. The AlphaClone Alterative Alpha ETF’s investment advisor is Exchange Traded Concepts LLC. The AlphaClone International ETF’s investment advisor is AlphaClone, Inc. The funds’ sub-advisor is Vident Investment Advisory LLC. AlphaClone, Inc. owns the indexes that underlie the funds. KCG Americas LLC is the funds’ lead market maker. Quasar is not affiliated with AlphaClone, Exchange Traded Concepts, Vident, or KCG Americas. The AlphaClone logo is a service mark of AlphaClone, Inc.


Gregory FCA for AlphaClone
Jen Micklow, 610-228-2148

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.